The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Jan 2015 07:00

RNS Number : 1936C
Horizon Discovery Group plc
15 January 2015
 



 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Horizon Discovery

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

Transaction in own shares

Yes

 

3. Full name of person(s) subject to the notification obligation: iii

Invesco Limited

4. Full name of shareholder(s)

(if different from 3.): iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

9 January 2015

6. Date on which issuer notified:

12 January 2015

7. Threshold(s) that is/are crossed or

reached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

GB00BK8FL363

3,975,000

3,975,000

3,975,000

4.98%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 3,975,000

 4.98%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

14. Contact name:

15. Contact telephone number:

 

 

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in shares xxii

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

Contact address

(registered office for legal entities)

Phone number & email

Other useful information

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Invesco (UK) Limited

Contact address

Perpetual Park, Perpetual Drive, Henley-on-Thames, Oxon, RG9 1HH

Phone number & email

01491417000

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FCA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBIMRTMBMBBFA
Date   Source Headline
8th Jul 20207:00 amRNSNotice of Trading Update & Capital Markets Webinar
26th Jun 20207:00 amRNSDirector/PDMR Shareholding
18th Jun 20201:00 pmRNSResult of AGM
18th Jun 20201:00 pmRNSDirector/PDMR Shareholding
5th Jun 20205:34 pmRNSHolding(s) in Company
4th Jun 202011:11 amRNSHoldings in Company
29th May 20207:00 amRNSDirector/PDMR Shareholding
22nd May 20207:00 amRNSAnnual Report and Notice of AGM
5th May 20205:46 pmRNSHolding(s) in Company
5th May 20201:34 pmRNSHolding(s) in Company
4th May 20201:58 pmRNSDirector/PDMR Shareholding
4th May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSBoard Changes
29th Apr 202010:43 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSFull Year Unaudited Results 2019
17th Apr 20203:56 pmRNSResults of Placing
17th Apr 202011:00 amRNSProposed Placing and COVID-19 update
3rd Apr 202011:35 amRNSHolding(s) in Company
2nd Apr 20204:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202010:56 amRNSHoldings in Company
27th Mar 20207:00 amRNSFull Year Results Deferral and COVID-19 Update
25th Mar 202011:20 amRNSHolding(s) in Company
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 202012:03 pmRNSPrice Monitoring Extension
27th Feb 202010:38 amRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSPresentation Cowen Annual Health Care Conference
17th Feb 20207:00 amRNSTotal Voting Rights
14th Feb 20202:46 pmRNSHolding(s) in Company
4th Feb 20207:00 amRNSConfidential submission of Form F-1 to SEC
4th Feb 20207:00 amRNSTrading Update
27th Jan 20201:51 pmRNSBlock Listing Six Monthly Return
14th Jan 20207:00 amRNSUpdate on Base Editing Technology License
18th Dec 20197:00 amRNSPresentation at J.P. Morgan Healthcare Conference
16th Dec 201912:07 pmRNSSecond Price Monitoring Extn
16th Dec 201912:02 pmRNSPrice Monitoring Extension
13th Dec 20197:00 amRNSCollaboration with Mammoth Biosciences
4th Dec 201912:08 pmRNSSecond Price Monitoring Extn
4th Dec 201912:02 pmRNSPrice Monitoring Extension
4th Dec 20197:00 amRNSCompletion of Divestment of In Vivo Business Unit
8th Nov 20197:00 amRNSDivestment of In Vivo Business Unit
22nd Oct 20193:22 pmRNSAdditional Block Listing and Total Voting Rights
4th Oct 201912:07 pmRNSSecond Price Monitoring Extn
4th Oct 201912:02 pmRNSPrice Monitoring Extension
19th Sep 20193:30 pmRNSHolding(s) in Company
16th Sep 20197:00 amRNSHalf-year Report
12th Aug 201912:07 pmRNSSecond Price Monitoring Extn
12th Aug 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20197:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.